Biosimilars: CMC Issues and Regulatory Requirements
Biosimilars: CMC Issues and Regulatory Requirements Reporter: Aviva Lev-Ari, PhD, RN Updated on 2/10/2014 Cambridge Healthtech Institute’s Fifth Annual Biotherapeutics Analytical Summit Hyatt...
View ArticleBiosimilars: Financials 2012 vs. 2008
Curator: Aviva Lev-Ari, PhD, RN For IP and Legal aspects of Biosimilars, go to: Biosimilars: Intellectual Property Creation and Protection by Pioneer and by Biosimilar Manufacturers...
View Article
More Pages to Explore .....